BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 27908280)

  • 21. The application of somatic CRISPR-Cas9 to conditional genome editing in Caenorhabditis elegans.
    Li W; Ou G
    Genesis; 2016 Apr; 54(4):170-81. PubMed ID: 26934570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA-guided genome editing in plants using a CRISPR-Cas system.
    Xie K; Yang Y
    Mol Plant; 2013 Nov; 6(6):1975-83. PubMed ID: 23956122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein.
    Tang L; Zeng Y; Du H; Gong M; Peng J; Zhang B; Lei M; Zhao F; Wang W; Li X; Liu J
    Mol Genet Genomics; 2017 Jun; 292(3):525-533. PubMed ID: 28251317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR-Cas9-assisted native end-joining editing offers a simple strategy for efficient genetic engineering in Escherichia coli.
    Huang C; Ding T; Wang J; Wang X; Guo L; Wang J; Zhu L; Bi C; Zhang X; Ma X; Huo YX
    Appl Microbiol Biotechnol; 2019 Oct; 103(20):8497-8509. PubMed ID: 31501938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic engineering of Escherichia coli using CRISPR-Cas9 meditated genome editing.
    Li Y; Lin Z; Huang C; Zhang Y; Wang Z; Tang YJ; Chen T; Zhao X
    Metab Eng; 2015 Sep; 31():13-21. PubMed ID: 26141150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome modification by CRISPR/Cas9.
    Ma Y; Zhang L; Huang X
    FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome editing of Francisella tularensis using (CRISPR-Cas9).
    Southern SJ; Oyston PCF
    J Microbiol Methods; 2020 Sep; 176():106004. PubMed ID: 32687866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering Citrobacter freundii using CRISPR/Cas9 system.
    Alfaro T; Elmore JR; Stromberg ZR; Hutchison JR; Hess BM
    J Microbiol Methods; 2022 Sep; 200():106533. PubMed ID: 35779647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Site-Specific Integration of Exogenous Genes Using Genome Editing Technologies in Zebrafish.
    Kawahara A; Hisano Y; Ota S; Taimatsu K
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted genome editing in the rare actinomycete Actinoplanes sp. SE50/110 by using the CRISPR/Cas9 System.
    Wolf T; Gren T; Thieme E; Wibberg D; Zemke T; Pühler A; Kalinowski J
    J Biotechnol; 2016 Aug; 231():122-128. PubMed ID: 27262504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR-Cas9
    Li Q; Seys FM; Minton NP; Yang J; Jiang Y; Jiang W; Yang S
    Biotechnol Bioeng; 2019 Jun; 116(6):1475-1483. PubMed ID: 30739328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient targeted mutagenesis in soybean by TALENs and CRISPR/Cas9.
    Du H; Zeng X; Zhao M; Cui X; Wang Q; Yang H; Cheng H; Yu D
    J Biotechnol; 2016 Jan; 217():90-7. PubMed ID: 26603121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coupling ssDNA recombineering with CRISPR-Cas9 for Escherichia coli DnaG mutations.
    Li J; Sun J; Gao X; Wu Z; Shang G
    Appl Microbiol Biotechnol; 2019 Apr; 103(8):3559-3570. PubMed ID: 30879090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A two-plasmid inducible CRISPR/Cas9 genome editing tool for Clostridium acetobutylicum.
    Wasels F; Jean-Marie J; Collas F; López-Contreras AM; Lopes Ferreira N
    J Microbiol Methods; 2017 Sep; 140():5-11. PubMed ID: 28610973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccinia Virus Genome Editing Using CRISPR.
    Di Gioia C; Yuan M; Wang Y
    Methods Mol Biol; 2019; 2023():109-117. PubMed ID: 31240673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-efficiency CRISPR/Cas9 multiplex gene editing using the glycine tRNA-processing system-based strategy in maize.
    Qi W; Zhu T; Tian Z; Li C; Zhang W; Song R
    BMC Biotechnol; 2016 Aug; 16(1):58. PubMed ID: 27515683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiplex Generation, Tracking, and Functional Screening of Substitution Mutants Using a CRISPR/Retron System.
    Lim H; Jun S; Park M; Lim J; Jeong J; Lee JH; Bang D
    ACS Synth Biol; 2020 May; 9(5):1003-1009. PubMed ID: 32348672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using the CRISPR/Cas9 system to eliminate native plasmids of Zymomonas mobilis ZM4.
    Cao QH; Shao HH; Qiu H; Li T; Zhang YZ; Tan XM
    Biosci Biotechnol Biochem; 2017 Mar; 81(3):453-459. PubMed ID: 27900888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of the genome editing tool CRISPR/Cas9 in non-human primates.
    Luo X; Li M; Su B
    Dongwuxue Yanjiu; 2016 Jul; 37(4):214-9. PubMed ID: 27469252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.